Skip to content

Awake Thoracic Epidural Anaesthesia Versus General Anesthesia for Video Assisted Thoracoscopic Surgery

Comparative Study Between Awake Thoracic Epidural Anaesthesia and General Anesthesia for Video Assisted Thoracoscopic Surgery

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03902470
Enrollment
60
Registered
2019-04-04
Start date
2019-05-01
Completion date
2021-07-31
Last updated
2019-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Brief summary

Thoracic procedures are routinely performed under general anesthesia (GA), with one lung ventilation (OLV)by double lumen tube or (GA) in spontaneously breathing patient by TIVA or LMA are usually combined with thoracic epidural analgesia. However, GA whether mechanically ventilated or spontaneously breathing may have adverse effects including peri-intubation hypoxia, trauma to the upper airway, mechanical ventilation-induced injuries, impaired cardiac performance, neuromuscular problems in OLV and increased risk of pneumonia, and release of proinflammatory mediators in generally. Recently, awake thoracic epidural anesthesia (ATEA) has been used alone in thoracic procedures The results achieved in early studies have been encouraging. ATEA may eventually provide an alternative method to GA for thoracic procedures that would not only eliminate the need for GA but also facilitate both surgical reconstruction and eventually patient recovery. Recent studies suggested better clinical outcomes with ATEA, including less intraoperative bleeding, a better control of postoperative pain, early mobilization and short hospital stay, oral intake tolerance, reduction of surgical stress response, reduction of intraoperative cardiac events, improvement of myocardial flow determinants and left ventricular function, and a reduction of complications including pulmonary, thrombotic and infectious events.

Interventions

PROCEDUREThoracic epidural anaesthesia video assisted thoracoscopic surgery

Patients in (TEA) group will pre-medicated using midazolam 3-4 mg (IV)and fentanyl 50 mcg (IV). Then An epidural catheter will be inserted between T3-T4 and T4-T5 . A test dose (5 ml) of 2% lidocaine will be given, followed by 15-20 ml of bupivacain 0.5%.

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

In determining a significant difference (20%) in the occurrence of postoperative pain score by using the power of 80% and a significance level of 5% and this will result in 30 patients in each group.

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Age range between 18 and 60 years. * ASA score equal to or less than III. * The absence of severe emphysema or clinical signs of active infectious disease. * The procedure is predicted to be completed within two hours.

Exclusion criteria

* Patients with expected difficult airway management * Haemodynamically unstable patients * Obesity (body mass index \>30) * Inexperienced and poorly cooperative surgical team * Coagulopathy (international normalized ratio \>1.5) * Persistent cough or high airway secretion * Neurological disorders: risk of seizure, unable to cooperate, intracranial mass or brain oedema * Extensive pleural adhesions or previous pulmonary resections * Hypoxaemia (PaO2 \<60) or hypercarbia (PCO2 \>50) * Any contraindications for use of regional anesthesia technique

Design outcomes

Primary

MeasureTime frameDescription
Recovery time after intervention of each group7daysThe time of anesthesia recovery, resumption of oral intake,and the length of hospital stay,postoperative recovery index will be used will be used to assess recovery as next Higher scores reflect greater difficulty in post-operative recovery No Difficulty 1 Little Difficulty \>1 to \<1.5 Moderate Difficulty 1.5 to \<2.5 Considerable Difficulty 2.5 to \<3.5 Extreme Difficulty 3.5 to 5 PoRI Scale and Subscale Scoring System.

Secondary

MeasureTime frameDescription
Patient agitation and sedation by using richmond agitation-sedation scale(RASS)4 hourly postoperative.1\. Observe patient 1. Patient is alert, restless, or agitated. (Score 0 to +4) 2. If not alert, state patient's name and say to open eyes and look at speaker. 2. Patient awakens with sustained eye opening and eye contact. (Score -1) 3. Patient awakens with eye opening and eye contact, but not sustained. (Score -2) 4. Patient has any movement in response to voice but no eye contact. (Score -3) 3. When no response to verbal stimulation, physically stimulate patient by shaking shoulder and/or rubbing sternum. 5. Patient has any movement to physical stimulation. (Score -4) 6. Patient has no response to any stimulation. (Score -5)

Other

MeasureTime frameDescription
Incidence of complications14daysImpaired cardiac performance assessed by Echo and incidence of pneumonia assessed by chest x-ray.

Contacts

Primary ContactMohamed Rabeea Ahmed
docmedo91@gmail.com01024475093

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026